FDX1 and liver cancer: The high expression of FDX1 exhibited a longer survival than the low-expression group in TCGA-LIHC, GSE14520, and the liver cancer project (code: LIRI_JP) of the International Cancer Genome Consortium (ICGC) (ICGC-LIRI) cohorts (15).